IP Library Granted Patent US 8,569,344
Granted Patent B2
US 8,569,344 · App. 13/601,357 · Granted Oct 29, 2013

N-piperidinyl acetamide derivatives as calcium channel blockers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,569,344
App. No.
13/601,357
Granted
Oct 29, 2013
Kind
B2
Abstract

Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted T-type calcium channel activity are disclosed. Specifically, a series of compounds containing N-piperidinyl acetamide derivatives as shown in formula (1).

Claims (6)

1. A method to treat a condition selected from chronic and acute pain, said method comprising administering to a subject in need of such treatment an amount of a pharmaceutical composition effective to ameliorate said condition, wherein said pharmaceutical composition comprises a compound having the structure,

or a pharmaceutically acceptable salt or conjugate thereof, in admixture with a pharmaceutically acceptable excipient.

2. The method of claim 1 , wherein said condition is chronic pain.

3. The method of claim 2 , wherein said chronic pain is peripheral neuropathic pain, central neuropathic, musculoskeletal pain, inflammatory pain, headache, visceral pain, or mixed pain.

4. The method of claim 3 , wherein said chronic pain is visceral pain.

5. The method of claim 1 , wherein said condition is acute pain.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2018
From: TARO PHARMACEUTICALS INC.
To: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF EPIRUS BIOPHARMACEUTICALS, INC.
Reel/Frame 047435/0416 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2018
From: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF EPIRUS BIOPHARMACEUTICALS, INC.
To: PRAXIS PRECISION MEDICINES, INC.
Reel/Frame 047445/0370 →
MERGER Recorded Mar 24, 2016
From: ZALICUS PHARMACEUTICALS LTD.
To: TARO PHARMACEUTICALS INC.
Reel/Frame 038091/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2013
From: PAJOUHESH, HASSAN; KAUL, RAMESH; DING, YANBING; ZHU, YONGBAO; ZHANG, LINGYUN; CHAKKA, NAGASREE; GRIMWOOD, MIKE; TAN, JASON; ZHOU, YUANXI
To: NEUROMED PHARMACEUTICALS, LTD.
Reel/Frame 031036/0018 →
CHANGE OF NAME Recorded Aug 19, 2013
From: NEUROMED PHARMACEUTICALS, LTD.
To: ZALICUS PHARMACEUTICALS LTD.
Reel/Frame 031036/0052 →